Citywire for Financial Professionals
Stay connected:

View the article online at http://citywire.co.uk/money/article/a758363

Woodford buys three tech stocks from Invesco

Neil Woodford has started to buy shares in several of his favourite technology firms from his former employer for his new fund.

 
Woodford buys three tech stocks from Invesco

Neil Woodford has started to buy shares in several of his favourite technology firms from his former employer.

The Citywire A-rated manager has snapped up exactly the same number of shares as Invesco Perpetual has sold in companies including ReNeuron (RQE), e-Therapeutics (ETXP) and Revolymer (REVO).

Woodford (pictured) had held stem-cell specialist ReNeuron through his former Invesco Perpetual Income and High Income funds in his St James’s Place mandate, and has now acquired 242 million shares for his new CF Woodford Equity Income fund. That stake is worth around £7 million and means Woodford now owns 14.9% of the company.

On the same day that Woodford bought his shares in ReNeuron, Invesco reduced its holding in the firm by 242 million shares.

Woodford has also been a long-standing investor in e-Therapeutics and has bought 18.2 million shares in the business for his new fund. That is worth around £5 million and takes Woodford’s ownership of e-Therapeutics to 17.7%. Again, Invesco cut its position in e-Therapeutics by the same number of shares on the same day.

Invesco Perpetual similarly sold 10 million shares in polymer developer Revolymer, worth almost £5 million, on the same day Woodford procured a stake of the same size.

Invesco Perpetual declined to comment on whether a deal had been struck between them over the formal transfer of holdings, while a spokesperson for Woodford Investment Management told Citywire that 'no conversations' had taken place between the two firms on the subject.

Other investments by Woodford for his new fund emphasise his interest in small-cap tech firms.

Benchmark Holdings (BMKB) listed only in December last year, for example, and focuses on biotechnology for aquaculture and agriculture. Woodford has initiated a position in Benchmark with the purchase of 8.5 million shares, equivalent to 6.2% of the firm and worth around £7 million.

He has furthermore committed to a stake worth around £86 million in Imperial Innovations (IVO) as part of the venture-capital firm’s fundraising.

Woodford has also allocated approximately £12.5 million to RM2 International (RM2), a Luxembourg-based pallet innovator that listed on AIM in January.

The CF Woodford Equity Income fund began trading last week, but Woodford has yet to reveal how much he raised during its offer period.

‘We don’t believe it would be sensible to announce the total amount raised for the fund immediately for reasons of market sensitivity and to protect investors in the fund,’ he explained.

‘However, we will announce this figure once the portfolio has largely taken shape and we expect the portfolio to be substantially invested by the end of June. In the interests of transparency and keeping our investors informed, we commit to providing full disclosure of the fund’s holdings on our website on a monthly basis.’

Woodford added: ‘I intend to proceed in a careful and considered manner, with a strong, disciplined focus on valuation – I won’t buy any share for the portfolio unless I view its valuation as attractive.’

4 comments so far. Why not have your say?

Fred via mobile

Jun 23, 2014 at 19:51

I have bought a fair chunk of Woodward and will look forward to seeing his investment list.

Rock on Neil

Banjo

report this

Brocklman

Jun 29, 2014 at 18:45

Time will tell

report this

Magic Monty

Jun 30, 2014 at 02:48

Sorry - I just can't see it - All those Pharma shares have never made a bean. As for RM2 it just makes plastic pallets.

Obvioiusly some Company in Asia will make the same thing cheaper and adjust some minor dimensions to avoid any patent issues.

Woodford seems to be the Guru of fund managers, hate to think about the rest of them and will keep doing my own thing and outperforming these guys without paying them a fee apart from my pension perhaps as that is part contributed by my company and is out of my control.

Time will out on the 3 pharma's mentioned and RM2 as always........

report this

Gillian Cardy

Jul 01, 2014 at 08:50

Could someone please explore the relationship between Neil Woodford and Woodford Funds, and The Excalibur Group, Sir Chris Evans, Martin Walton - and the impact this may have on the choices of underlying investments - and in the light of CF's previously noted issues about managing conflicts of interests, what steps are in place to protect investors??

report this

leave a comment

Please sign in here or register here to comment. It is free to register and only takes a minute or two.

News sponsored by:

The Citywire Guide to Investment Trusts


In this guide to investment trusts, produced in association with Aberdeen Asset Management, we spoke to many of the leading experts in the field to find out more.

Watch Now

More about this:

Look up the funds

  • Invesco Perpetual Income Inc
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them
  • Invesco Perpetual High Income Inc
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them

Look up the shares

  • ReNeuron Group PLC (RQE.L)
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them
  • E-Therapeutics PLC (ETXP.L)
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them
  • Benchmark Holdings PLC (BMKB.L)
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them
  • Revolymer PLC (REVO.L)
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them
  • Imperial Innovations Group PLC (IVO.L)
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them
  • RM2 International SA (RM2.L)
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them

Look up the fund managers

  • Neil Woodford
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them

More from us

Archive

Today's articles

Tools from Citywire Money

From the Forums

+ Start a new discussion

Weekly email from The Lolly

Get simple, easy ways to make more from your money. Just enter your email address below

An error occured while subscribing your email. Please try again later.

Thank you for registering for your weekly newsletter from The Lolly.

Keep an eye out for us in your inbox, and please add noreply@emails.citywire.co.uk to your safe senders list so we don't get junked.

Read more...

The Accumulator: Santa rally still on the cards

by Daniel Grote on Dec 15, 2017 at 15:50

Sorry, this link is not
quite ready yet